Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittorio Dibello

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Alzheimer'S Disease : JAD|November 24, 2025
Gustatory dysfunction and oral frailty: Emerging implications for Alzheimer's diseaseFrancesco Panza, Madia Lozupone, Emanuela Resta, et al.
Neural Regeneration Research|March 27, 2025
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disordersMadia Lozupone, Ivana Leccisotti, Anita Mollica, et al.
The Lancet. Healthy Longevity|September 13, 2022
Oral frailty and its determinants in older age: a systematic reviewVittorio Dibello, Roberta Zupo, Rodolfo Sardone, et al.
Ageing Research Reviews|July 11, 2024
Oral health indicators and bone mineral density disorders in older age: A systematic reviewVittorio Dibello, Frank Lobbezoo, Vincenzo Solfrizzi, et al.
Expert Opinion on Drug Discovery|April 30, 2024
Lessons learned from the failure of solanezumab as a prospective treatment strategy for Alzheimer's diseaseMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Journal of Oral Rehabilitation|December 20, 2025
Tooth Loss as a Risk Factor of Declining Intrinsic Capacity Domains in Later Life: Evidence From NHANES 2009-2014Vittorio Dibello, Karl G H Parisius, Frank Lobbezoo, et al.
Expert Opinion on Drug Discovery|April 12, 2023
The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathiesMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Opinion on Biological Therapy|February 5, 2025
Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's diseaseFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Opinion on Emerging Drugs|August 11, 2020
Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugsMadia Lozupone, Vincenzo Solfrizzi, Francesca D'Urso, et al.
Expert Opinion on Emerging Drugs|June 20, 2026
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's diseaseMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Alzheimer'S Disease : JAD|November 24, 2025
Gustatory dysfunction and oral frailty: Emerging implications for Alzheimer's diseaseFrancesco Panza, Madia Lozupone, Emanuela Resta, et al.
Neural Regeneration Research|March 27, 2025
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disordersMadia Lozupone, Ivana Leccisotti, Anita Mollica, et al.
The Lancet. Healthy Longevity|September 13, 2022
Oral frailty and its determinants in older age: a systematic reviewVittorio Dibello, Roberta Zupo, Rodolfo Sardone, et al.
Ageing Research Reviews|July 11, 2024
Oral health indicators and bone mineral density disorders in older age: A systematic reviewVittorio Dibello, Frank Lobbezoo, Vincenzo Solfrizzi, et al.
Expert Opinion on Drug Discovery|April 30, 2024
Lessons learned from the failure of solanezumab as a prospective treatment strategy for Alzheimer's diseaseMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Journal of Oral Rehabilitation|December 20, 2025
Tooth Loss as a Risk Factor of Declining Intrinsic Capacity Domains in Later Life: Evidence From NHANES 2009-2014Vittorio Dibello, Karl G H Parisius, Frank Lobbezoo, et al.
Expert Opinion on Drug Discovery|April 12, 2023
The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathiesMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Opinion on Biological Therapy|February 5, 2025
Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's diseaseFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Expert Opinion on Emerging Drugs|August 11, 2020
Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugsMadia Lozupone, Vincenzo Solfrizzi, Francesca D'Urso, et al.
Expert Opinion on Emerging Drugs|June 20, 2026
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's diseaseMadia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Pageof 7